APA (7th ed.) Citation

Y, L., N, A., M, O., JR, M., I, I., Q, L., . . . DA, S. (2022). Treatment with a VEGFR-2 antibody results in intra-tumor immune modulation and enhances anti-tumor efficacy of PD-L1 blockade in syngeneic murine tumor models. PloS one, 17(7), e0268244. https://doi.org/10.1371/journal.pone.0268244

Chicago Style (17th ed.) Citation

Y, Li, et al. "Treatment with a VEGFR-2 Antibody Results in Intra-tumor Immune Modulation and Enhances Anti-tumor Efficacy of PD-L1 Blockade in Syngeneic Murine Tumor Models." PloS One 17, no. 7 (2022): e0268244. https://doi.org/10.1371/journal.pone.0268244.

MLA (9th ed.) Citation

Y, Li, et al. "Treatment with a VEGFR-2 Antibody Results in Intra-tumor Immune Modulation and Enhances Anti-tumor Efficacy of PD-L1 Blockade in Syngeneic Murine Tumor Models." PloS One, vol. 17, no. 7, 2022, p. e0268244, https://doi.org/10.1371/journal.pone.0268244.